Healthcare -
Biotechnology - NASDAQ - US
$ 1.83
-1.08 %
$ 399 M
Market Cap
-8.32
P/E
AKBA - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss AKBA - Akebia Therapeutics, Inc.
6 K
LAST VALUE
0.00%
2 YEAR CAGR
15.13%
5 YEAR CAGR
20.91%
10 YEAR CAGR